Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children

NCT: NCT05997979 · RECRUITING

NCT IDNCT05997979
StatusRECRUITING
Start Date2024-03-05
Completion2028-07-05
SponsorUniversity Hospital, Brest (OTHER)
First posted
Last updated

Brief Summary

This study concerns children aged to 12 to 17-years with local chronic neuropathic pain after trauma or surgery. It is a multicentric randomized controlled superiority trial in parallel arms : * experimental arm: Capsaicin 8% cutaneous patch * controlled arm : Hydrocolloid dressing Treatment with capsaicin application is realized at baseline, and repeated 3 months after the first patch application if needed. Tolerance is assessed during each application and by phone call in following days until stop of cold need. Efficacy is assessed monthly by clinical consultation until the end of the study (month 4).

Frequently Asked Questions

What is Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children?

Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children is a clinical trial registered under NCT05997979. Current status: RECRUITING.

What is the status of NCT05997979?

The current status of NCT05997979 (Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children) is: RECRUITING.

When did Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children start?

Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children started on 2024-03-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.